Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP73168.RAlZhWl5NNtjpV4w5x7P1wdmN1rDeR-q9IC7_Mn5-QeWU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP73168.RAlZhWl5NNtjpV4w5x7P1wdmN1rDeR-q9IC7_Mn5-QeWU130_assertion type Assertion NP73168.RAlZhWl5NNtjpV4w5x7P1wdmN1rDeR-q9IC7_Mn5-QeWU130_head.
- NP73168.RAlZhWl5NNtjpV4w5x7P1wdmN1rDeR-q9IC7_Mn5-QeWU130_assertion description "[both HTR2C and HTR2A gene polymorphisms seem to be associated with the occurrence of metabolic abnormalities in patients treated with olanzapine or clozapine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP73168.RAlZhWl5NNtjpV4w5x7P1wdmN1rDeR-q9IC7_Mn5-QeWU130_provenance.
- NP73168.RAlZhWl5NNtjpV4w5x7P1wdmN1rDeR-q9IC7_Mn5-QeWU130_assertion evidence source_evidence_literature NP73168.RAlZhWl5NNtjpV4w5x7P1wdmN1rDeR-q9IC7_Mn5-QeWU130_provenance.
- NP73168.RAlZhWl5NNtjpV4w5x7P1wdmN1rDeR-q9IC7_Mn5-QeWU130_assertion SIO_000772 19142110 NP73168.RAlZhWl5NNtjpV4w5x7P1wdmN1rDeR-q9IC7_Mn5-QeWU130_provenance.
- NP73168.RAlZhWl5NNtjpV4w5x7P1wdmN1rDeR-q9IC7_Mn5-QeWU130_assertion wasDerivedFrom gad-20130706 NP73168.RAlZhWl5NNtjpV4w5x7P1wdmN1rDeR-q9IC7_Mn5-QeWU130_provenance.
- NP73168.RAlZhWl5NNtjpV4w5x7P1wdmN1rDeR-q9IC7_Mn5-QeWU130_assertion wasGeneratedBy ECO_0000203 NP73168.RAlZhWl5NNtjpV4w5x7P1wdmN1rDeR-q9IC7_Mn5-QeWU130_provenance.